(S)-1-(Pyridin-2-yl)ethanamine dihydrochloride, 95.0%, 10g

3-(Chloromethyl)-2-methoxypyridine hydrochloride, 95.0%, 5g

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate, 97.0%, 500g

Yodo, mínimo 99,5 %, resublimado, 500 g, envase de vidrio

2-(1-propylpiperidin-4-yl)ethanamine, 95.0%, 1g

2,2'-(((3,4-Dihydroxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)methyl)azanediyl)diacetic acid, 97.0%, 10g

(S)-2-Amino-3-(benzyloxy)propan-1-ol, 95.0%, 10g

(3S,4S,5R,6R)-6-(Acetoxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate, 95.0%, 25g

N-(4-Aminobutyl)-N-ethylisoluminol, 95.0%, 100mg

5-Bromo-2,4-dihydroxybenzaldehyde, 97%, 1g

1-methyl-1H-indazole-3-carbonitrile, 95.0%, 1g

1-tert-Butyl 3-ethyl 3-allylpiperidine-1,3-dicarboxylate, 98%, 5g

1,4-Bis(2-methylstyryl)benzene, 98.0%, 5g